Mr. Mucci has supported Curetis GmbH as a Clinical Trial Consultant for validation of a multiplex PCR-based rapid pathogen detection diagnostic test.  Mr.  Mucci has served as the Head of Study Management at Epigenomics AG where he oversaw multiple clinical studies enrolling over 8,000 subjects for the validation of a blood-based molecular diagnostic colorectal cancer detection test.

He has worked with the United States National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research (OBBR) to develop the foundation for the Cancer Human BioBank (caHUB) and the Biospecimen Research Network (BRN) initiatives. Mr. Mucci has also supported the National Cancer Institute (NCI) with the Clinical Proteomics Tumor Analysis Consortium (CPTAC) Project and The Cancer Genome Atlas (TCGA) Project, as well as the National Human Genome Research Institute (NHGRI) with the Genome Tissue Expression (GTEx) Project.

Prior to Epigenomics, Mr. Mucci was a founder of the human tissue services company Asterand PLC where he served as Director of Laboratory Operations, Director of Quality Assurance, and Director of Strategic Alliances.  At Asterand Mr. Mucci was responsible for establishing and managing clinical biospecimen collection programs at over 100 institutions in over 10 countries around the world.

Prior to joining Asterand, Mr. Mucci supervised the Prostate Cancer Tissue Core Facility at the University of Michigan Specialized Program of Research Excellence (UM Prostate SPORE) where he co-authored scientific articles on tissue procurement, tissue microarrays, surrogate end-point biomarker development, and telepathology.

Prior to joining GBC, Ms. Maas served as Clinical Study Manager at Epigenomics AG, where she managed multiple clinical research studies and oversaw biorepository operations and biospecimen informatics. Previous to Epigenomics, Ms. Maas was Quality Control Specialist at Northwest Tissue Center in Seattle, WA, where she was responsible for transplant tissue processing records; managing operational deviations; and auditing internal and external vendor procedures for compliance with FDA regulations, industry standards, and internal SOPs. Ms. Maas holds a professional certificate in Clinical Trials.